Hydronephrosis surgery

Jump to navigation Jump to search

Hydronephrosis Microchapters


Patient Information


Historical Perspective




Differentiating Hydronephrosis from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings


X Ray



Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hydronephrosis surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Hydronephrosis surgery

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hydronephrosis surgery

CDC on Hydronephrosis surgery

Hydronephrosis surgery in the news

Blogs on Hydronephrosis surgery

Directions to Hospitals Treating Hydronephrosis

Risk calculators and risk factors for Hydronephrosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]


Surgery is the mainstay of treatment for Hydronephrosis. The type of surgery depends on the underlying cause and also depending on whether the obstruction is acute or chronic.


Surgery is the mainstay of treatment for hydronephrosis. The type of surgery depends on the underlying cause and also depending on whether the obstruction is acute or chronic. Surgical options include:[1][2][3][4][5][6][7]

  • Urethral stenting
    • Unilateral
    • Bilateral
  • Pyleoplasty
  • Per-cutaneous nephrostomy
  • Percutaneous ureterostony


  1. Liu KL, Lee BC, Ye JD, Chang YH, Chang CC, Huang KH, Lee YJ, Chang YC (July 2018). "Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients". Eur Radiol. doi:10.1007/s00330-018-5560-6. PMID 29974220.
  2. Şimşir A, Kızılay F, Semerci B (April 2018). "Comparison of percutaneous nephrostomy and double J stent in symptomatic pregnancy hydronephrosis treatment". Turk J Med Sci. 48 (2): 405–411. doi:10.3906/sag-1711-5. PMID 29714462. line feed character in |title= at position 61 (help)
  3. Li B, Liu DB, Gong EM (June 2018). "Robot-assisted laparoscopic transplant-to-native ureteroureterostomy of an intraperitoneal renal allograft". J Pediatr Urol. doi:10.1016/j.jpurol.2018.06.008. PMID 30017605.
  4. Shrestha AL, Bal HS, Kisku S, Sen S (June 2018). "Outcome of end cutaneous ureterostomy (ECU) as a non conservative option in the management of primary obstructive megaureters (POM)". J Pediatr Urol. doi:10.1016/j.jpurol.2018.05.004. PMID 29937413. Vancouver style error: initials (help)
  5. Baek M, Silay MS, Au JK, Huang GO, Elizondo RA, Puttmann KT, Janzen NK, Seth A, Roth DR, Koh CJ (July 2018). "Does the use of 5 mm instruments affect the outcomes of robot-assisted laparoscopic pyeloplasty in smaller working spaces? A comparative analysis of infants and older children". J Pediatr Urol. doi:10.1016/j.jpurol.2018.06.010. PMID 30007500.
  6. Young M, Stavas J. PMID 29630257. Missing or empty |title= (help)
  7. Onen A (2007). "Treatment and outcome of prenatally detected newborn hydronephrosis". J Pediatr Urol. 3 (6): 469–76. doi:10.1016/j.jpurol.2007.05.002. PMID 18947797. Unknown parameter |month= ignored (help)

Template:WH Template:WS